• iPSC Prescreening for Ultrarare Disease Trials

  2026-08-14

  Sequiera et al. developed a patient-specific iPSC platform to evaluate treatment candidates before clinical-trial enrollment in an ultrarare Leigh-like mitochondrial disorder. The study shows how genetically matched, multisystem models can reduce trial-and-error decision-making while also clarifying the limits of translating cellular metabolic responses into clinical benefit.

• Hexetidine in Oral Antiseptic Research: 1981 Evidence

  2026-08-14

  The 1981 study linked in vitro susceptibility testing with matrix interference and persistence of antibacterial activity in human saliva. Its central implication is that MIC ranking alone cannot predict oral antiseptic performance, because retention and activity in the salivary environment also influence plaque-related outcomes.

• Carbapenemase Spread in Enterobacter cloacae

  2026-08-13

  A 2025 multicenter study mapped carbapenemase-encoding genes, their genomic locations, transferability, mobile genetic elements, and clonal relationships in 54 carbapenem-resistant Enterobacter cloacae isolates from eight Guangdong teaching hospitals. The findings identify plasmid-borne blaNDM-1 as a major dissemination route and show why resistance surveillance must combine phenotypic testing with molecular and epidemiological analyses.

• Cdc42–GSK-3β/β-Catenin Signaling in Kidney Fibrosis

  2026-08-13

  A 2024 Advanced Science study identified daphnepedunin A as a natural small molecule that targets Cdc42 and limits renal fibrosis in fibroblast and unilateral ureteral obstruction models. Its mechanistic contribution is the connection of Cdc42 activity with PKCζ, GSK-3β, and β-catenin turnover, providing a rationale for studying Cdc42-directed interventions in chronic kidney disease.

• TH287: Reframing MTH1-Driven Radiosensitization

  2026-08-12

  TH287 converts oxidative nucleotide stress into a radiosensitizing liability. This thought-leadership analysis connects MTH1 biology with CRPC radiation research, highlights the importance of treatment timing, and defines the experimental controls needed for credible translational decisions.

• 17-AAG (Tanespimycin) Research Workflows

  2026-08-12

  Build reproducible HSP90 inhibition experiments with 17-AAG (Tanespimycin), from fresh stock preparation and dose-response design to client-protein validation and apoptosis profiling. The workflow also shows how a recent norovirus study can sharpen interpretation of cell death, membrane rupture, and selective protein release without overstating antiviral evidence.

• Cefiderocol Against Resistant European Non-Fermenters

  2026-08-11

  The reference study directly compares cefiderocol with recent β-lactam/β-lactamase inhibitor combinations across a large European collection of Pseudomonas aeruginosa and Acinetobacter spp., including meropenem-resistant isolates. Its susceptibility data and molecular analysis support parallel early testing of cefiderocol and comparator agents, while also showing why in vitro activity should not be equated automatically with clinical efficacy.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody Workflow

  2026-08-10

  Build reproducible immunofluorescence, IHC, ICC, and flow cytometry workflows around a Cy3-conjugated secondary antibody for rabbit primary antibody detection. This guide connects the reagent to the Inonotus obliquus polysaccharide rheumatoid arthritis study, translating its NF-κB and NLRP3 validation strategy into practical assay design and troubleshooting decisions.

• HRP Goat Anti-Mouse IgG: Assay Design Guide

  2026-08-09

  Learn how an Affinity-Purified Goat Anti-Mouse IgG (H+L), HRP Conjugated secondary antibody supports sensitive, interpretable immunoassays. This guide connects assay design with recent tumor-microbiome research and practical decisions for Western blotting, ELISA, IHC, and ICC.

• Metformin Hydrochloride in Ossification Research

  2026-08-08

  Metformin Hydrochloride extends beyond glucose studies into mechanistic models of tendon-derived osteogenesis and heterotopic ossification. This workflow-focused guide covers formulation, dose finding, pathway validation, and troubleshooting for reproducible metabolic and musculoskeletal experiments.

• PMSF in Shrimp Immune Assay Design

  2026-08-07

  Phenylmethanesulfonyl fluoride (PMSF) can protect soluble protein measurements, but its value depends on the assay endpoint. This guide connects PMSF selection with recent shrimp hemocyte epigenetic and extracellular-vesicle research to define where protease control improves interpretation—and where it does not.

• Endothelial SGK1 Regulates Salt-Induced Vascular Stiffening

  2026-08-07

  Zhang et al. (2024) provide direct evidence that endothelial SGK1 mediates vascular stiffening in response to high salt and aldosterone, using both genetic deletion and pharmacological inhibition. Their findings clarify the mechanistic link between sodium channel regulation, actin polymerization, and cardiovascular risk, supporting SGK1 inhibition as a targeted research approach.

• Cefiderocol’s In Vitro Efficacy vs. Resistant Enterobacteral

  2026-08-06

  This study systematically evaluates the in vitro activity of cefiderocol against a large European collection of Enterobacterales, including isolates resistant to meropenem and modern β-lactam/β-lactamase inhibitor combinations. The findings provide robust comparative susceptibility data, informing clinical and research strategies for multidrug-resistant Gram-negative infections.

• Fludarabine as a Precision Immunomodulator in Oncology Resea

  2026-08-06

  Explore how Fludarabine, a purine analog DNA synthesis inhibitor, uniquely reshapes the tumor antigenic landscape to enhance T cell therapies. Uncover advanced immunomodulatory mechanisms and practical assay insights that go beyond standard leukemia research.

• Hexetidine (NSC-17764): Advanced Workflows for Oral Biofilm

  2026-08-05

  Hexetidine (NSC-17764) stands out as a versatile antibacterial agent for oral infections, offering robust activity against bacteria and fungi even within biofilms. This guide delivers actionable protocol enhancements, troubleshooting strategies, and a comparative analysis to help researchers optimize experimental workflows for oral health and infection models.

452 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page